1. Medtech Insight
  2. >>Geography
  3. >>Europe
  4. >>United Kingdom

UK Competition Watchdog Has Concerns About Stryker/Wright Medical Merger

 
• By Phil Greenfield

The UK Competition and Markets Authority has concerns over the impact on the market for ankle replacements that would result from Stryker's planned $4bn acquisition of Wright Medical.

Magnifier
• Source: Shutterstock

The UK Competition and Markets Authority (CMA) has said that if Stryker Corp.’s purchase of Wright Medical Group NV went ahead, it would have a negative impact on patients in the UK who need ankle replacements. Following an initial investigation, the CMA found that the proposed merger would result in the combined company having a share of over 90% of the total ankle replacement prostheses market in the UK.

CMA senior director Joel Bamford said: “The CMA is concerned that this merger and the resulting reduction in competition could lead to worse outcomes for hospitals and patients. The companies...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

More from Europe

23andMe Purchase Will Let Regeneron Scale Drug Development

 
• By Alaric DeArment

The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.

Disparities — Including Financial Shortcomings — Remain In Women’s Health, Execs Say

 
• By Brian Bossetta

FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.

Thousands Of Cardiac Digital Twins Reveal Novel Connections With Mental Health

 
• By Natasha Barrow

King’s College London, Imperial College London and The Alan Turing Institute constructed cardiac digital twins at scale, creating over 3,400, in a new study using UK Biobank data published in Nature Cardiovascular Research on 16 May.